WRIC

Lilly's AWARD-PEDS trial investigating use of Trulicity® (dulaglutide) in youth and adolescents with type 2 diabetes showed superiority in A1C reduction vs placebo

"The incidence of type 2 diabetes among youth and adolescents is on the rise, particularly among minority populations, and the disease can be even more progressive and difficult to treat than in ...

Trulicity Market Size to Reach USD 15.30 Billion by 2035 with Strong Demand for Metabolic Treatments | SNS Insider

U.S. Trulicity Market to Reach USD 4.87 Billion by 2035 Driven by Rising Diabetes PrevalenceAustin, May 04, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, The Trulicity Market size was valued at ...
Healthline

Trulicity and Cost: What You Need to Know

If you’re looking at treatment options for type 2 diabetes, you may want to learn more about Trulicity (dulaglutide). It’s a prescription drug used in adults to help with the following: Trulicity ...
CNN

Trulicity® (dulaglutide) is the first and only type 2 diabetes medicine approved to reduce cardiovascular events in adults with and without established cardiovascular disease

The new indication reflects the differentiated patient population of REWIND, the Trulicity cardiovascular outcomes trial. While all participants had CV risk factors, the study consisted primarily of ...